None listed
Conditions
Brief summary
The purpose of this study is to prospectively evaluate the benefits of frequent AV/PV and V-V delay optimisation using QuickOpt in patients iwth CRT-D devices
Interventions
The study is aimed at demonstrating that frequent AV/PV and V-V delay optimisation using QuickOpt in patients with Cardiac Resynchronisation Therapy Defibrillation devices results in improved clinical response over standard of care (i.e. empiric programming or one-time optimisation using any non-intracardiac electrogram optimisation methods). SJM has developed inter-ventricular (V-V) delay optimisation to synchronize the electrical activation of the conducted intrinsic and paced wavefronts between the pacing electrodes. The Atrio-ventricular (AV/PV) optimisation method characterises the inter-atrial conduction patterns in order to maximise preload and allow for proper timing of mitral valve closure. The intervention is observed for a period of 12 months, from which time the device will remain implanted.
Sponsors
Study design
Eligibility
Inclusion criteria
- Patient meets current CRT-D indications and be implanted with a St. Jude Medical (SJM) CRT-D device with V-V timing and a copatible lead system. - Patient has the ability to complete a 6-minute hall walk with the only limiting factor to be fatigue or shortness of breath -Patient has the ability to independantly comprehend and complete a Quality Of Life (QOL) questionnaire - Patient is geographically stable and willing to coply with the required follow up schedule
Exclusion criteria
- Patient has an epicardial ventricular lead system -patient has the ability to walk greater or equal to 450 meters in 6 meters - Patient has limited intrinsic atrial activity (<40bpm) - Patient has persistent or permanent Atrial Fibrillation (AF) - Patient has a 2 or 3 degree heart block - Patients life expectancy is less than a year - Patient is less than 18yrs old - Patient is pregnant - Patient is on an Intravenous (IV) inotropic agent